Literature DB >> 33169272

Compressive force strengthened the pro-inflammatory effect of zoledronic acid on il-1ß stimulated human periodontal fibroblasts.

Sarah Grimm1, Ambili Mundethu2, Judit Symmank3, Christoph Hennig3, Christian Walter4, Elisabeth Reichardt5, Heiner Wehrbein2, Collin Jacobs3.   

Abstract

OBJECTIVES: The number of patients in dentistry taking bisphosphonates (BP) increases every year. There are only little data about the influence of biomechanical stress due to orthodontic treatment and periodontal inflammation in BP patients. This study focused on the effects of the induced inflammation by IL-1ß in compressed human periodontal ligament fibroblasts (HPdLF) exposed to the nitrogen-containing BP zoledronate in vitro.
MATERIALS AND METHODS: HPdLF were incubated with 5 μmol/l zoledronate and 10 ng/ml IL-1ß for 48 h. In the last 3 h, cells were exposed to a compressive, centrifugal force of 34.9 g/cm2. Cell viability was analyzed directly after the compressive force by MTT assay. Gene expression of COX-2 and IL-6 was investigated using quantitative qRT-PCR. PGE-2 and IL-6 protein secretion were measured via ELISA.
RESULTS: The cell viability of HPdLF was not affected. Without inflammatory pre-stimulation, COX-2 expression was increased by compression and zoledronate. IL-6 expression was increased under compression. On secretion level, the combination of compression and zoledronate induced a slightly increase of IL-6 secretion. In contrast, inflammatory pre-stimulation strengthened the compressive upregulation of COX-2, as well as induced a higher PGE-2 secretion. Further addition of zoledronate to pre-stimulated cells additionally strengthened the compression-induced upregulation of COX-2 and IL-6 expression as well as protein secretion compared to all other groups.
CONCLUSIONS: Biomechanical stress might trigger a pro-inflammatory potential of BP further enhanced in the presence of an inflammatory pre-stimulation. CLINICAL RELEVANCE: To prevent excessive host inflammatory responses, occlusal overloading and mechanical stress due to orthodontic treatment should be avoided in BP patients with untreated periodontitis.

Entities:  

Keywords:  Bisphosphonates; COX-2; IL-6; Orthodontics

Year:  2020        PMID: 33169272     DOI: 10.1007/s00784-020-03667-w

Source DB:  PubMed          Journal:  Clin Oral Investig        ISSN: 1432-6981            Impact factor:   3.573


  36 in total

1.  The tissue, cellular, and molecular regulation of orthodontic tooth movement: 100 years after Carl Sandstedt.

Authors:  Murray C Meikle
Journal:  Eur J Orthod       Date:  2006-05-10       Impact factor: 3.075

2.  The influence of bisphosphonates on viability, migration, and apoptosis of human oral keratinocytes--in vitro study.

Authors:  Andreas M Pabst; Thomas Ziebart; Felix P Koch; Katherine Y Taylor; Bilal Al-Nawas; Christian Walter
Journal:  Clin Oral Investig       Date:  2011-01-12       Impact factor: 3.573

3.  Novel insights into actions of bisphosphonates on bone: differences in interactions with hydroxyapatite.

Authors:  G H Nancollas; R Tang; R J Phipps; Z Henneman; S Gulde; W Wu; A Mangood; R G G Russell; F H Ebetino
Journal:  Bone       Date:  2005-07-20       Impact factor: 4.398

4.  Influence of bisphosphonates on endothelial cells, fibroblasts, and osteogenic cells.

Authors:  C Walter; M O Klein; A Pabst; B Al-Nawas; H Duschner; T Ziebart
Journal:  Clin Oral Investig       Date:  2009-03-18       Impact factor: 3.573

Review 5.  The use of bisphosphonates in patients with breast cancer.

Authors:  Catherine H Van Poznak
Journal:  Cancer Control       Date:  2002 Nov-Dec       Impact factor: 3.302

6.  High-dose zoledronic acid impacts bone remodeling with effects on osteoblastic lineage and bone mechanical properties.

Authors:  Samantha Pozzi; Sonia Vallet; Siddhartha Mukherjee; Diana Cirstea; Nileshwari Vaghela; Loredana Santo; Eyal Rosen; Hiroshi Ikeda; Yutaka Okawa; Tanyel Kiziltepe; Jesse Schoonmaker; Wanling Xie; Teru Hideshima; Edie Weller; Mary L Bouxsein; Nikhil C Munshi; Kenneth C Anderson; Noopur Raje
Journal:  Clin Cancer Res       Date:  2009-09-08       Impact factor: 12.531

7.  Trends in osteoporosis treatment with oral and intravenous bisphosphonates in the United States, 2002-2012.

Authors:  Diane K Wysowski; Patty Greene
Journal:  Bone       Date:  2013-09-21       Impact factor: 4.398

8.  Effects of an oral bisphosphonate and three intravenous bisphosphonates on several cell types in vitro.

Authors:  Junho Jung; Jung Soo Park; Leonardo Righesso; Andreas Max Pabst; Bilal Al-Nawas; Yong-Dae Kwon; Christian Walter
Journal:  Clin Oral Investig       Date:  2018-02-01       Impact factor: 3.573

Review 9.  Adverse effects of bisphosphonates: current issues.

Authors:  Ingo J Diel; Raoul Bergner; Knut A Grötz
Journal:  J Support Oncol       Date:  2007 Nov-Dec

10.  Bisphosphonate-induced orbital inflammation in a patient on chronic immunosuppressive therapy.

Authors:  Isabella Herrera; Yong Kam; Thomas J Whittaker; Mary Champion; Radwan S Ajlan
Journal:  BMC Ophthalmol       Date:  2019-02-14       Impact factor: 2.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.